Diabetic Peripheral Neuropathy:治療薬のグローバル治験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Peripheral Neuropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Peripheral Neuropathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Diabetic Peripheral Neuropathy Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Diabetic Peripheral Neuropathy 33
Oct 18, 2013: Pfizer Reports Top-Line Results From Two Lyrica Capsules CV Phase 3b Studies 33
Nov 27, 2012: Intellipharmaceutics Announces Results Of Initial Phase I Clinical Trial Of Controlled-release Pregabalin 34
Aug 29, 2012: RegeneRx Reports That Thymosin Beta 4 Promotes Recovery Of Peripheral Neuropathy In Type II Diabetic Mice 34
May 04, 2012: Pfizer Reports Top-Line Results From Phase III Trial Of Lyrica Capsules CV In Patients With Diabetic Peripheral Neuropathy 34
Feb 21, 2012: SK Biopharmaceuticals Initiates Phase II Trials In US 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Nestle Health Science S.A. 38
Clinical Trial Overview of Nestle Health Science S.A. 38
Takeda Pharmaceutical Company Limited 39
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 39
Grunenthal GmbH 40
Clinical Trial Overview of Grunenthal GmbH 40
Daiichi Sankyo Company, Limited 41
Clinical Trial Overview of Daiichi Sankyo Company, Limited 41
Astellas Pharma Inc. 42
Clinical Trial Overview of Astellas Pharma Inc. 42
SK Biopharmaceuticals Co., Ltd. 43
Clinical Trial Overview of SK Biopharmaceuticals Co., Ltd. 43
Johnson & Johnson 44
Clinical Trial Overview of Johnson & Johnson 44
C. H. Boehringer Sohn AG & Co. KG 45
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 45
Clinical Trial Overview of Top Institutes / Government 46
University of Michigan 46
Clinical Trial Overview of University of Michigan 46
Hamedan University of Medical Sciences 47
Clinical Trial Overview of Hamedan University of Medical Sciences 47
Inha University Hospital 48
Clinical Trial Overview of Inha University Hospital 48
Joslin Diabetes Center 49
Clinical Trial Overview of Joslin Diabetes Center 49
The University of Melbourne 50
Clinical Trial Overview of The University of Melbourne 50
University of Surrey 51
Clinical Trial Overview of University of Surrey 51
Loma Linda University 52
Clinical Trial Overview of Loma Linda University 52
Islamic Azad University of Tabriz 53
Clinical Trial Overview of Islamic Azad University of Tabriz 53
University of Missouri 54
Clinical Trial Overview of University of Missouri 54
University of Calgary 55
Clinical Trial Overview of University of Calgary 55
Five Key Clinical Profiles 56
Appendix 125
Abbreviations 125
Definitions 125
Research Methodology 126
Secondary Research 126
About GlobalData 127
Contact Us 127
Disclaimer 127
Source 127


【レポート販売概要】

■ タイトル:Diabetic Peripheral Neuropathy:治療薬のグローバル治験動向(2014年上半期)
■ 英文:Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2133CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。